GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Return on Assets (ROA) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| ROA(%) | 25.40 | 25.15 | 17.87 | 15.76 | 10.11 |
What is the latest Return on Assets (ROA) ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Return on Assets (ROA) |
|---|---|
| Mar2026 | 25.40 |
| Mar2025 | 25.15 |
| Mar2024 | 17.87 |
| Mar2023 | 15.76 |
| Mar2022 | 10.11 |
How is Return on Assets (ROA) of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Return on Assets (ROA) | % Change | |
|---|---|---|---|
| Mar2026 | 25.4 | 0.99 | |
| Mar2025 | 25.15 | 40.74 | |
| Mar2024 | 17.87 | 13.39 | |
| Mar2023 | 15.76 | 55.89 | |
| Mar2022 | 10.11 | - | |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Assets (ROA) ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹37,248.5 Cr | 1.2% | -9.8% | -37.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,667.0 Cr | 0.8% | -4.2% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,805.0 Cr | 1.1% | -0.7% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,554.0 Cr | 0% | 1.3% | 40.1% | Stock Analytics | |
| CIPLA | ₹109,120.0 Cr | -0.3% | -4.1% | -8.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,920.0 Cr | 0.4% | -4.5% | -5.2% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 1.2% |
-9.8% |
-37.5% |
| SENSEX | 4.3% |
2.6% |
-6.4% |
You may also like the below Video Courses